189 related articles for article (PubMed ID: 16126325)
21. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
[TBL] [Abstract][Full Text] [Related]
22. Oncological outcome after radical cystectomy and orthotopic bladder substitution in women.
Ali-El-Dein B
Eur J Surg Oncol; 2009 Mar; 35(3):320-5. PubMed ID: 18434072
[TBL] [Abstract][Full Text] [Related]
23. Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?
Mazzucchelli R; Barbisan F; Scarpelli M; Lopez-Beltran A; van der Kwast TH; Cheng L; Montironi R
Am J Clin Pathol; 2009 Feb; 131(2):279-83. PubMed ID: 19141388
[TBL] [Abstract][Full Text] [Related]
24. Lack of progress in early diagnosis of bladder cancer.
Araki M; Nieder AM; Manoharan M; Yang Y; Soloway MS
Urology; 2007 Feb; 69(2):270-4. PubMed ID: 17320662
[TBL] [Abstract][Full Text] [Related]
25. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
26. Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer.
Leibovici D; Kamat AM; Pettaway CA; Pagliaro L; Rosser CJ; Logothetis C; Pisters LL
J Urol; 2005 Dec; 174(6):2186-90. PubMed ID: 16280761
[TBL] [Abstract][Full Text] [Related]
27. The maximum tumour length in biopsy cores as a predictor of outcome after radical prostatectomy.
Hayashi N; Urashima M; Kuruma H; Arai Y; Kuwao S; Iwamura M; Egawa S
BJU Int; 2008 Jan; 101(2):175-80. PubMed ID: 17850362
[TBL] [Abstract][Full Text] [Related]
28. Cystoprostatectomy as a treatment of prostate cancer involving the bladder neck.
Kumazawa T; Tsuchiya N; Saito M; Inoue T; Narita S; Horikawa Y; Yuasa T; Satoh S; Kato T; Nanjyo H; Habuchi T
Urol Int; 2009; 83(2):141-5. PubMed ID: 19752606
[TBL] [Abstract][Full Text] [Related]
29. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
30. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
[TBL] [Abstract][Full Text] [Related]
31. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
[TBL] [Abstract][Full Text] [Related]
32. Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis.
Dell'Atti L
Arch Ital Urol Androl; 2015 Mar; 87(1):76-9. PubMed ID: 25847902
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
34. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients.
Botto H; Sebe P; Molinie V; Herve JM; Yonneau L; Lebret T
BJU Int; 2004 Nov; 94(7):1021-5. PubMed ID: 15541120
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of pT2 subdivisions in the TNM staging system for prostate cancer.
Hong SK; Han BK; Chung JS; Park DS; Jeong SJ; Byun SS; Choe G; Lee SE
BJU Int; 2008 Nov; 102(9):1092-6. PubMed ID: 18671786
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer.
Macdonald OK; Lee RJ; Snow G; Lee CM; Tward JD; Middleton AW; Middleton GW; Sause WT
Urology; 2007 Feb; 69(2):295-9. PubMed ID: 17320667
[TBL] [Abstract][Full Text] [Related]
37. Treatment delay and prognosis in invasive bladder cancer.
Liedberg F; Anderson H; Månsson W
J Urol; 2005 Nov; 174(5):1777-81; discussion 1781. PubMed ID: 16217282
[TBL] [Abstract][Full Text] [Related]
38. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
39. Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.
Yang X; Monn MF; Liu L; Liu Y; Su J; Lyu T; Gong Y; Wang L; Davidson DD; Cheng L
Prostate; 2015 Jun; 75(8):845-54. PubMed ID: 25704311
[TBL] [Abstract][Full Text] [Related]
40. Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique.
Montironi R; Cheng L; Mazzucchelli R; Scarpelli M; Kirkali Z; Montorsi F; Lopez-Beltran A
Eur Urol; 2009 Jun; 55(6):1305-9. PubMed ID: 18995951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
